4NZ2
Crystal structure of CYP2C9 in complex with an inhibitor
Summary for 4NZ2
Entry DOI | 10.2210/pdb4nz2/pdb |
Related | 4NY4 |
Descriptor | Cytochrome P450 2C9, PROTOPORPHYRIN IX CONTAINING FE, GLYCEROL, ... (6 entities in total) |
Functional Keywords | cytochrome p-450, cyp2c9, inhibitor, structure-based drug design, drug metabolism, monooxygenase, oxidoreductase-oxidoreductase inhibitor complex, oxidoreductase/oxidoreductase inhibitor |
Biological source | Homo sapiens (human) |
Cellular location | Endoplasmic reticulum membrane; Peripheral membrane protein: P11712 |
Total number of polymer chains | 2 |
Total formula weight | 110919.84 |
Authors | Branden, G.,Sjogren, T.,Xue, Y. (deposition date: 2013-12-11, release date: 2014-08-13, Last modification date: 2024-02-28) |
Primary citation | Branden, G.,Sjogren, T.,Schnecke, V.,Xue, Y. Structure-based ligand design to overcome CYP inhibition in drug discovery projects. Drug Discov Today, 19:905-911, 2014 Cited by PubMed: 24642031DOI: 10.1016/j.drudis.2014.03.012 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.45 Å) |
Structure validation
Download full validation report